OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 685 results

Filters: long-acting PrEP

Preferences and Acceptability for Long-Acting PrEP Agents Among Pregnant and Postpartum Women with Experience Using Daily Oral PrEP in South Africa and Kenya
Wara, N. J.; Mvududu, R.; Marwa, M.; Gomez, L.; Mashele, N.; Orrell, C.; Moucheraud, C.; Kinuthia, J.; John-Stewart, G.; Myer, L.; Hoffman, R.; Pintye, J.; Joseph Davey, D. L.
medrxiv. 2022-10-30. Preprint
Source:medrxiv
PPRID: 10.1101/2022.10.29.22281701v1 doi:NA
Intention and preference for long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach
Wang, H.; Zimmermann, H. M. L.; van de Vijver, D.; Jonas, K. J.
medrxiv. 2022-11-11. Preprint
Source:medrxiv
PPRID: 10.1101/2022.11.11.22282218v1 doi:NA
User Preferences on Long-Acting Pre-Exposure Prophylaxis for HIV Prevention in Sub-Saharan Africa: A Scoping Review
Pfau, B. A.; Saravis, A.; Cox, S.; Wu, L.; Wittenauer, R.; Callen, E.; Arrouzet, C.; Sharma, M.
medrxiv. 2024-04-02. Preprint
Source:medrxiv
PPRID: 10.1101/2024.04.01.24305173v1 doi:NA
Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort.
Erin E Cooney, Sari L Reisner, Tonia C Poteat, Asa E Radix, Kenneth H Mayer, Chris Beyrer, Meg Stevenson, Rodrigo A Aguayo-Romero, Jason S Schneider, Andrew J Wawrzyniak, Christopher M Cannon, Carolyn A Brown, Leigh Ragone, Vani Vannappagari, Andrea L Wirtz, American Cohort to Study HIV Acquisition Among Transgender Women (LITE) Study Group
AJPM Focus. Apr, 2025.4(2):100313 Electronic-eCollection
Source:PubMed
PMID: 40051448 doi:10.1016/j.focus.2025.100313
Cabotegravir long-acting for HIV-1 prevention.
Chasity D Andrews, Walid Heneine
Curr Opin HIV AIDS. Jul, 2015.10(4):258-63 Print
Source:PubMed
PMID: 26049951 doi:10.1097/COH.0000000000000161
Pharmacists and the next generation of HIV pre-exposure prophylaxis.
Kamron Griffith, Frank Romanelli
J Am Pharm Assoc (2003). 2022 Sep-Oct.62(5):1542-1545 Print-Electronic
Source:PubMed
PMID: 35961938 doi:10.1016/j.japh.2022.07.001
Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
Marjolein M van Vliet, Cheryl Hendrickson, Brooke E Nichols, Charles Ab Boucher, Remco Ph Peters, David Amc van de Vijver
J Int AIDS Soc. 12, 2019.22(12):e25427 Print
Source:PubMed
PMID: 31855323 doi:10.1002/jia2.25427
Preferences for long-acting pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey.
Jing-Hao Hsu, Stephane Wen-Wei Ku, Tsai-Wei Chen, Chia-Wen Li, Poyao Huang, Huei-Jiuan Wu, Adam Bourne, Carol Strong
J Int AIDS Soc. 09, 2023.26(9):e26163 Print
Source:PubMed
PMID: 37675767 doi:10.1002/jia2.26163
Transforming HIV prevention: the promise of long-acting preexposure prophylaxis in high HIV burden settings.
Dvora Joseph Davey, Sumaya Dadan, Nafisa Wara
Curr Opin HIV AIDS. Jan 01, 2025.20(1):32-38 Print-Electronic
Source:PubMed
PMID: 39561011 doi:10.1097/COH.0000000000000895
High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy.
Angelo Roberto Raccagni, Laura Galli, Maria Francesca Lucente, Caterina Candela, Riccardo Lolatto, Benedetta Trentacapilli, Giacomo Ponta, Emanuela Messina, Nicola Gianotti, Antonella Castagna, Silvia Nozza
AIDS Behav. Mar, 2024.28(3):907-911 Print-Electronic
Source:PubMed
PMID: 37792228 doi:10.1007/s10461-023-04197-8
0